Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157: Miracle Healing Peptide or Hidden Danger? FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Moves on Peptides: What Compounding Pharmacies Need to Know FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157 Banned: Key Facts on the Latest FDA Decision